References Acosta, Andres, Alejandro Campos, Alan De la Rosa, Fauzi Feris, Wissam Ghusn, Lizeth Cifuentes, Maria Daniela Hurtado, and Daniel Sacoto Weight Loss Outcomes Associated With Semaglutide Treatment for Patients With Overweight or Obesity Hims & Hers Newsroom Hims & Hers is Delivering a New GLP-1
If constipation persists, consult your healthcare provider for personalized advice and potential adjustments to your treatment plan
Similarly, in the class IIIII obesity subgroup (BMI 35.0 kg/m), live birth rates were 9.4% in the semaglutide group compared with 16.6% in controls (OR = 0.52, 95% CI 0.340.80, p = 0.0024)
Treatment of animals Four groups of Sprague-Dawley rats housed under the same conditions and fed on the same diet were used in this experiment